Literature DB >> 17638635

Hypercalcaemic crisis: immediate parathyroidectomy and intraoperative intravenous calcium infusion improves outcome.

Kaur Harjit1, Hussein Zanariah, Abdullah N Hisham.   

Abstract

The hypercalcaemic crisis of hyperparathyroidism is an endocrine emergency that is invariably fatal if untreated. Despite emergency parathyroidectomies to treat hypercalcaemic crisis, mortality rates remain high. The rapid decline of serum calcium levels after removal of an adenoma and its adverse effect on the heart contributes to the development of postoperative complications and death. The cornerstone of surgical treatment for hypercalcaemic crisis is to begin infusion of high doses of calcium immediately after successful removal of parathyroid adenomas to allow gradual and well-controlled decline of serum calcium to avoid fatal myocardial complications.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17638635     DOI: 10.1016/s1015-9584(08)60018-4

Source DB:  PubMed          Journal:  Asian J Surg        ISSN: 1015-9584            Impact factor:   2.767


  4 in total

1.  Peripherally inserted central catheters for calcium requirements after successful parathyroidectomy: a comparison with centrally inserted catheters.

Authors:  H J Qi; W W Yang; L D Zhang; X J Shi; Q Y Li; T Ye
Journal:  Ann R Coll Surg Engl       Date:  2017-05       Impact factor: 1.891

2.  Anesthetic considerations in hyperparathyroid crisis: A case report.

Authors:  Hao Kong; Zhen Zhang; Hong Zhang
Journal:  Medicine (Baltimore)       Date:  2021-01-08       Impact factor: 1.817

3.  Management and surgical treatment of parathyroid crisis secondary to parathyroid tumors: report of four cases.

Authors:  Shakil Ameerudden; Xianghui He
Journal:  Int Med Case Rep J       Date:  2011-08-15

4.  Novel calcium infusion regimen after parathyroidectomy for renal hyperparathyroidism.

Authors:  Jih Huei Tan; Henry Chor Lip Tan; Seng Cheong Loke; Sarojah A/P Arulanantham
Journal:  Nephrology (Carlton)       Date:  2017-04       Impact factor: 2.506

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.